Hislop Colin
Insider CIK 1314902 · ANTH Chief Medical Officer · VSAR Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VSAR Versartis, Inc. | S Sale | 2017-10-19 | 2017-10-23 | 667 | $2.55 | $1.7K | 23,833 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise deriv | 2017-04-04 | 2017-04-05 | 35,000 | — | $0 | 188,100 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise | 2017-04-04 | 2017-04-05 | 35,000 | $8.17 | $285.9K | 59,500 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-04-04 | 2017-04-05 | 35,000 | $21.20 | $742.0K | 24,500 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2017-01-27 | 2017-01-31 | 43,700 | — | $0 | 43,700 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-01-27 | 2017-01-31 | 19,500 | — | $0 | 24,500 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2016-10-11 | 2016-10-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2016-04-04 | 2016-05-02 | 223,100 | — | $0 | 223,100 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2016-02-12 | 2016-02-16 | 10,848 | — | $0 | 10,848 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2015-11-13 | 2015-11-18 | 12,500 | $5.31 | $66.4K | 19,147 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | M Exercise | 2015-11-13 | 2015-11-18 | 12,500 | $1.61 | $20.1K | 31,647 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2015-11-11 | 2015-11-12 | 5,000 | $5.38 | $26.9K | 19,147 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2015-09-17 | 2015-09-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2015-09-17 | 2015-09-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | M Exercise deriv | 2014-12-30 | 2015-11-18 | 12,500 | — | $0 | 107,500 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2014-12-30 | 2015-01-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2014-03-25 | 2014-03-27 | 12,871 | — | $0 | 12,871 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | F Tax w/h | 2014-03-25 | 2014-03-27 | 3,323 | — | $0 | 20,283 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award | 2014-03-25 | 2014-03-27 | 3,864 | — | $0 | 24,147 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2013-05-17 | 2013-05-21 | 1,300,000 | — | $0 | 1,300,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award | 2013-03-25 | 2013-03-27 | 59,132 | — | $0 | 144,091 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | F Tax w/h | 2013-01-03 | 2013-01-07 | 4,560 | $0.69 | $3.1K | 84,959 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2012-03-30 | 2012-04-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | M Exercise deriv | 2012-02-23 | 2012-02-27 | 40,000 | — | $0 | 50,447 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | M Exercise | 2012-02-23 | 2012-02-27 | 40,000 | $0.26 | $10.4K | 79,519 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award | 2012-02-06 | 2012-02-06 | 9,923 | — | $0 | 39,519 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2012-02-03 | 2012-02-06 | 30,000 | $8.20 | $246.0K | 27,967 | SEC↗ |